SequelSEC

Airsculpt Technologies, Inc. AIRS

Services-Offices & Clinics of Doctors of Medicine · CIK 0001870940 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$151.82M
Fiscal year ended 2025-12-31
Operating income
-$11.56M
Fiscal year ended 2025-12-31
Free cash flow
$692.00K
Fiscal year ended 2025-12-31

Airsculpt Technologies, Inc. (AIRS) reported revenue of $151.82M and net income of -$11.67M for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Airsculpt Technologies, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.

Income

Airsculpt Technologies, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$151.82M$180.35M$195.92M$168.79M$133.32M$62.77M$41.24M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$11.56M-$1.58M$9.72M-$4.54M$15.77M$10.03M$663.00K
Net income-$11.67M-$8.02M-$4.24M-$14.68M$10.55M$7.58M-$2.21M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 60.45Mshares 57.69Mshares 56.78Mshares 55.68Mshares 55.64MUnavailableUnavailable
Pretax income-$17.64M-$7.83M$3.24M-$11.30M$10.88M$7.58M-$2.21M
Income tax expense-$5.97M$188.00K$7.48M$3.38M$329.00K$0$0
Diluted EPS$-0.19$-0.14$-0.08$-0.26$-0.01UnavailableUnavailable
Selling, general & administrative$82.18M$98.88M$102.38M$101.42M$65.73M$23.62M$20.12M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Airsculpt Technologies, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash & equivalents$8.45M$8.24M$10.26M$9.62M$25.35M$10.38MUnavailable
Total assets$187.30M$212.78M$204.02M$200.76M$200.55M$179.61MUnavailable
Current assets$15.46M$17.12M$15.96M$16.68M$29.44M$11.56MUnavailable
Total liabilities$99.59M$134.59M$120.03M$129.99M$117.03M$55.93MUnavailable
Current liabilities$27.90M$28.95M$20.32M$22.32M$16.42M$9.46MUnavailable
Total equity incl. NCI$87.71M$78.19M$82.66M$70.77M$83.53MUnavailableUnavailable
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Goodwill$81.73M$81.73M$81.73M$81.73M$81.73M$81.73MUnavailable
Long-term debt$50.58M$65.46M$69.50M$81.42M$81.76M$32.12MUnavailable
Accounts payable$5.37M$6.26M$3.92M$3.84M$2.67M$1.10MUnavailable

Cash flow

Airsculpt Technologies, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating cash flow$3.10M$11.35M$23.96M$24.45M$26.63M$13.96M$4.94M
Capital expenditures$2.40M$14.01M$9.92M$12.92M$7.12M$3.69M$4.44M
Investing cash flow-$2.40M-$14.01M-$9.92M-$12.92M-$7.12M-$3.69M-$4.44M
Financing cash flow-$478.00K$630.00K-$13.39M-$27.26M-$4.55M-$5.02M-$783.00K
Net change in cash$214.00K-$2.03M$646.00K-$15.73M$14.97M$5.25M-$284.00K
Stock-based compensation$2.33M$3.76M$18.22M$29.46M$7.18M$325.00K$341.00K
Common dividends paid$0$252.00K$385.00K$23.16M$0$0Unavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$12.78M$11.89M$10.25M$8.06M$6.60M$5.64M$4.96M

Derived

Airsculpt Technologies, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Free cash flow$692.00K-$2.66M$14.04M$11.53M$19.52M$10.27M$499.00K
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-7.6%-0.9%5.0%-2.7%11.8%16.0%1.6%
FCF margin0.5%-1.5%7.2%6.8%14.6%16.4%1.2%
SBC / revenue1.5%2.1%9.3%17.5%5.4%0.5%0.8%
Current ratio0.55x0.59x0.79x0.75x1.79x1.22xUnavailable
Revenue YoY growth-15.8%-7.9%16.1%26.6%112.4%52.2%Unavailable
Net margin-7.7%-4.4%-2.2%-8.7%7.9%12.1%-5.4%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue1.6%7.8%5.1%7.7%5.3%5.9%10.8%
Long-term debt / equity0.58xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailable231.0%Unavailable3.0%0.0%Unavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AIRS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K/A · Filed 2026-04-06View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-01View SEC filing

Companies in the same industry

CDIX HIMS HLYK LFMD SBC STLN TDOC

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-12-31

Difference 1335000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.